在与代谢功能障碍相关的脂肪肝炎相关的肝脏疾病中,铁质的参与
Yiran Liu1,2, Mingyu Zhang1,2, Yujie Huang1,2
1Department of Gastroenterology, Tongji Hospital, Tongji Medical College, HuazhongUniversity of Science and Technology, Wuhan, China.
概括
铁,一种细胞死亡途径,涉及铁和脂质过氧化,对于代谢功能障碍相关的脂肪肝炎 (MASH) 的进展至关重要. 向铁致死提供了一个有前途的治疗策略,用于MASH和相关的肝脏疾病.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是全球慢性肝病的主要原因.
- 代谢功能障碍相关的脂肪肝炎 (MASH) 是一种严重的MASLD形式,其特点是炎症和可能进展为纤维化和癌症.
- 细胞死亡途径与MASH病原发生有关,而铁亡成为一个关键参与者.
研究的目的:
- 审查铁灭的机制.
- 阐明铁质在MASLD和MASH进展中的作用,包括肝纤维化和肝细胞癌.
- 在MASH中探索向铁亡的治疗潜力.
主要方法:
- 文献综述总结了MASLD/MASH中铁亡的当前研究.
- 分析铁亡和其他细胞死亡方式之间的相互作用.
- 讨论针对铁亡的治疗策略.
主要成果:
- 铁,一种依赖铁的细胞死亡,以脂质过氧化为标志,在MASH中越来越多地被识别出来.
- 铁致死有助于MASLD向MASH,肝纤维化和肝细胞癌的进展.
- 铁亡与其他细胞死亡途径 (细胞亡,亡,自,热亡) 之间的相互作用在MASH中具有重要意义.
结论:
- 铁化是MASH发育和进展的关键机制.
- 向铁化为MASH治疗提供了一个有前途的治疗途径.
- 对铁灭细胞调节的进一步研究可能会导致新的MASH疗法.
相关概念视频
Necrosis
6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Protein Import into the Peroxisomes
5.2K
Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
Liver Physiology
3.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.5K


